Intravenous administration of Gr-1+CD11b+ myeloid cells increases neovascularization and improves cardiac function after heart infarction

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1702-1705

  Huang, Jianhua ^a,b,d   Lv, Gang ^a   Min, Yongfen ^b,c   Yang, Li ^b,c   Lin, P Charles ^b,c  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Medical University   (China)

Author keywords

Angiogenesis; Cell therapy; Heart infarction; Vasculogenesis

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CD31 ANTIBODY; CD31 ANTIGEN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE MARROW CELL; CAPILLARY DENSITY; CELL CULTURE; CELL SELECTION; CELL THERAPY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; GR 1+ CD11B+ MYELOID CELL; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION; VASCULAR RING;

ANGIOGENESIS; CELL THERAPY; GR-1+CD11B+ MYELOID CELLS; HEART INFARCTION; VASCULOGENESIS;

ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTIGENS, CD11B; BONE MARROW TRANSPLANTATION; MICE; MICE, INBRED C57BL; MYELOID CELLS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CHEMOKINE;

EID: 84885298474     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.069     Document Type: Article

References (9)

1. Yang L, DeBusk LM, Fukuda K, et al. Expansion of myeloid Immune suppressor Gr+CD11b+ cells In tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004;6:409-21.
2. Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006;124:175-89.
3. Kim JA, March K, Chae HD, et al. Muscle-derived Gr1(dim)CD11b(+) cells enhance neovascularization In an Ischemic hind limb mouse model. Blood 2010;116(9):1623-6.
4. Wara AK, Croce K, Foo S, et al. Bonemarrow-derived CMPs and GMPs represent highly functional proangiogenic cells: Implications for Ischemic cardiovascular disease. Blood 2011;118(24):6461-4.
5. Ljung BM,Mayall B, Lottich C, et al. Cell dissociation techniques In human breast cancer-variations In tumor cell viability and DNA ploidy. Breast Cancer Res Treat 1989;13:153-9.
6. Huang L, Sankar S, Lin C, et al. HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. J Biol Chem 1999;274:38183-8.
7. Lin P, Polverini P, Dewhirst M, Shan S, Rao PS, Peters K. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 In pathologic vascular growth. J Clin Invest 1997;100:2072-8.
8. Zhang R, Khoo MS, Wu Y, et al. Calmodulin kinase II Inhibition protects against structural heart disease. Nat Med 2005;11:409-17.
9. Takahashi K, Ito Y, MorikawaM, et al. Adenoviral-delivered angiopoietin-1 reduces the Infarction and attenuates the progression of cardiac dysfunction In the rat model of acute myocardial Infarction. Mol Ther 2003;8:584-92.